Earnings Per Share, Basic in USD/shares of Freeline Therapeutics Holdings plc from 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Freeline Therapeutics Holdings plc quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to Q1 2023.
  • Freeline Therapeutics Holdings plc Earnings Per Share, Basic for the quarter ending March 31, 2023 was 0.02 USD/shares.
  • Freeline Therapeutics Holdings plc annual Earnings Per Share, Basic for 2022 was -1.5 USD/shares, a 61.8% increase from 2021.
  • Freeline Therapeutics Holdings plc annual Earnings Per Share, Basic for 2021 was -3.93 USD/shares, a 42.3% increase from 2020.
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

Freeline Therapeutics Holdings plc Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $0.02 +$0.65 Jan 1, 2023 Mar 31, 2023 6-K 2023-05-30
Q1 2022 -$1 Jan 1, 2022 Mar 31, 2022 6-K 2023-05-30

Freeline Therapeutics Holdings plc Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$2 +$2.43 +61.8% Jan 1, 2022 Dec 31, 2022 20-F 2023-04-04
2021 -$4 +$2.88 +42.3% Jan 1, 2021 Dec 31, 2021 20-F 2023-04-04
2020 -$7 Jan 1, 2020 Dec 31, 2020 20-F 2023-04-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.